Drugs / PF03635659
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00864786 | Sep 2008 → Mar 2009 | chronic obstructive pulmonary disease | Pfizer | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01033487 | Jan → Jun 2010 | chronic obstructive pulmonary disease | Pfizer | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-03635659 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01033487 ↗ |
| Known as | PF-3635659 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1910856 ↗ |
| Modality | Small molecule | — CHEMBL1910856 ↗ |
| Route | Inhaled | “Inhaled doses of 200 mcgQD” NCT00864786 ↗ |